AG00I96L

51264-14-3 | Methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-

AG00I96L

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	51264-14-3
Catalog Number	AG00I96L(AGN-PC-0JK65E)
Chemical Name	Methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-
EC Number	257-094-3
IUPAC Name	N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
InChI	InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChI Key	XCPGHVQEEXUHNC-UHFFFAOYSA-N
MDL Number	MFCD00242748
Molecular Formula	C21H19N3O3S
Molecular Weight	393.4589
NSC Number	249992
SMILES	CS(=O)(NC1=CC=C(NC2=C(C=CC=C3)C3=NC4=CC=CC=C42)C(OC)=C1)=O
UNII	00DPD30SOY
Synonyms	AMSA, AMSA P D, AMSA P-D, AMSA PD, Amsacrina, Amsacrine, Amsidine, Amsidyl, Cain Acridine, Cain's Acridine, Cains Acridine, m-AMSA, meta AMSA, meta-AMSA, NSC 141549, NSC 156303, NSC 249992, NSC-141549, NSC-156303, NSC-249992, NSC141549, NSC156303, NSC249992, SN 11841, SN-11841, SN11841, amsacrine, 51264-14-3, m-AMSA, Amsidine, Amsidyl, Acridinylanisidide, Amsacrina, mAMSA, AMSA, Amsacrinum, Lamasine, Amekrin, Amsine, meta-Amsacrine, Acridinyl Anisidide, 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide, Amsacrinum [INN-Latin], Amsacrina [INN-Spanish], 4'-(9-Acridinylamino)methanesulfon-m-anisidide, CI-880, NSC249992, NSC 156303, NSC 249992, C21H19N3O3S, 4'-(9-Acridinylamino)methanesulphon-m-anisidide, SN 21429, SN-11841, UNII-00DPD30SOY, NSC-249992, N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide, CCRIS 1027, 4'-(9-Acridinylamino)methanesulfon-meta-anisidide, Methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-, HSDB 7087, CHEMBL43, N-[4-(9-Acridinylamino)-3-methoxyphenyl]methanesulfonamide, EINECS 257-094-3, CI 880, NSC-141549, NSC-156303, BRN 0500176, 00DPD30SOY, CHEBI:2687, Methanesulfonanilide, 4'-(9-acridinylamino)-3'-methoxy-, N-(4-(9-Acridinylamino)-3-methoxyphenyl)methanesulfonamide, Methanesulfonamide, N-(4-(9-acridinylamino)-3-methoxyphenyl)-, XCPGHVQEEXUHNC-UHFFFAOYSA-N, Methanesulfon-m-anisidide, 4'-(9-acridinylamino)-, N-[4-(acridin-9-ylamino)-3-(methyloxy)phenyl]methanesulfonamide, Cain's Acridine, meta-AMSA, Amecrin, N-(4-(Acridin-9-ylamino)-3-methoxyphenyl)methanesulfonamide, N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide, AMSA P-D, MLS002153376, nAMSA, Amsacrine [USAN:BAN:INN], Amsidyl (TN), Amsacrine (USAN/INN), SMR000875352, AMSA, M-, SN11841, Amsacrine [USAN:INN:BAN], Lopac-A-9809, NCIMech_000607, AC1L1D3L, Neuro_000118, SCHEMBL4047, Lopac0_000154, 5-22-11-00030 (Beilstein Handbook Reference), MLS006010099, cid_148673, DTXSID4022604, BDBM87351, KS-00000TTN, N-[4-(9-Acridinylamino)-3-methoxy-phenyl]methanesulfonamide, BCP08958, ZINC3812923, CCG-35555, AKOS015917522, API0001484, CS-1942, DB00276, LS-1319, NCI-249992, VA10050, NCGC00015113-01, NCGC00015113-02, NCGC00015113-03, NCGC00015113-04, NCGC00162077-01, AK547842, AN-41266, AS-11665, HY-13551, NCI60_001995, SMR000857391, WLN: T C666 BNJ IMR BO1 DMSW1, AB1004823, FT-0708980, C01553, D02321, 32319-EP2275420A1, 32319-EP2277865A1, 32319-EP2280012A2, 32319-EP2281815A1, 32319-EP2289892A1, 32319-EP2292615A1, 32319-EP2295055A2, 32319-EP2295416A2, 32319-EP2295426A1, 32319-EP2295427A1, 32319-EP2298748A2, 32319-EP2298764A1, 32319-EP2298765A1, 32319-EP2298768A1, 32319-EP2301928A1, 32319-EP2301933A1, 32319-EP2305640A2, 32319-EP2305642A2, 32319-EP2305671A1, 32319-EP2311453A1, 32319-EP2311808A1, 32319-EP2311827A1, 32319-EP2311829A1, 32319-EP2311840A1, 4'-(9-Acridinylamino)methanesulfonyl m-anisidide, 115830-EP2295416A2, 115830-EP2298748A2, 301A154, 4'-(9-Acridinylamino)-methylsulfonyl-m-anisidine, I14-9555, AMSA;m-AMSA;CI-880;SN-11841;acridinyl anisidide, Methanesulfonamide,N-[4-(9-acridinylamino)-3-methoxyphenyl]-, N-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide;hydrochloride, N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide;hydrochloride, N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide;hydrochloride, N-{4-[(ACRIDIN-9-YL)AMINO]-3-METHOXYPHENYL}METHANESULFONAMIDE, ASW, N-[4-(Acridin-9-ylamino)-3-(methyloxy)phenyl]methanesulfonamide; N-[4-(acridin-9-ylmethyl)-3-methoxyphenyl]methanesulfonamide, amsidil, Amsacrine hydrochloride, Cains Acridine, Cain Acridine, meta AMSA, m-Amsa hydrochloride, AMSA PD, AMSA P D, Acridinyl anisidide (TN), D0G9YH, M-AMSA (TN), CID2179, 51264-14-3 (Amsacrine), C21-H19-N3-O3-S, NSC141549, NSC156303, NSC 141549, SN 11841, B1302, A13093, D000677, N-[4-(acridin-9-ylmethyl)-3-methoxyphenyl]methanesulfonamide, 54301-15-4,

Complexity	601
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	393.115g/mol
Formal Charge	0
Heavy Atom Count	28
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	393.461g/mol
Monoisotopic Mass	393.115g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	88.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335-H350-H360
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number